Thomas A. Fitzgerald

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas A. Fitzgerald
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas A. Fitzgerald:

Company Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Interim CEO, CFO, Director Common Stock 56,318 $28,722 $0.5100 28 Sep 2023 Direct
Transcode Therapeutics, Inc. Interim CEO, CFO, Director Stock Option (right to buy) 650,000 14 Jun 2024 Direct

Insider Reports Filed by Thomas A. Fitzgerald

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAZ Transcode Therapeutics, Inc. 14 Jun 2024 1 $0 4 Interim CEO, CFO, Director 18 Jun 2024, 16:15
RNAZ Transcode Therapeutics, Inc. 28 Sep 2023 1 +$25,168 4 Chief Financial Officer, Director 02 Oct 2023, 16:39
RNAZ Transcode Therapeutics, Inc. 19 May 2023 1 $0 4 Chief Financial Officer, Director 19 May 2023, 20:07
RNAZ Transcode Therapeutics, Inc. 12 Dec 2022 1 $0 4 Chief Financial Officer, Director 14 Dec 2022, 19:13
RNAZ Transcode Therapeutics, Inc. 16 Jun 2022 1 +$15,240 4 Chief Financial Officer, Director 17 Jun 2022, 16:01
RNAZ Transcode Therapeutics, Inc. 01 Mar 2022 1 $0 4 Chief Financial Officer, Director 02 Mar 2022, 17:12
RNAZ Transcode Therapeutics, Inc. 01 Feb 2022 1 $0 4 Chief Financial Officer, Director 03 Feb 2022, 05:04
RNAZ Transcode Therapeutics, Inc. 08 Jul 2021 0 $0 3 VP, Chief Financial Officer, Director 08 Jul 2021, 21:53